NÍVEIS SÉRICOS DE 25(OH)-VITAMINA D EM PACIENTES COM OBESIDADE GRAU 2 E 3
Keywords:
Vitamina D, Obesidade, Síndrome metabólica, DiabetesAbstract
Introdução: Deficiência de vitamina D é reconhecida hoje como pandemia e fator de impacto no desenvolvimento de várias doenças, sendo recentemente relacionada à fisiopatologia da obesidade e da síndrome metabólica.
Objetivos: Analisar os níveis séricos de vitamina D em pacientes obesos em avaliação pré-operatória para cirurgia bariátrica correlacionando-os com variáveis clínicas, laboratoriais e epidemiológicas.
Métodos: Estudo observacional transversal, com 170 pacientes obesos grau 2 e 3 avaliados no ambulatório de cirurgia bariátrica do HU-UFSC em 2013. Foram coletados dados clínicos, epidemiológicos, antropométricos e laboratoriais.
Resultados: A média de idade foi de 40 ? 10 anos, sendo a maioria do sexo feminino, caucasiana e habitante do litoral. O peso e o IMC médios foram 126,0 ? 24,2 kg e 48,0 ? 7,1 kg/m² respectivamente. As comorbidades mais prevalentes foram diabetes mellitus tipo 2 (24,7%) e hipertensão arterial sistêmica (55,3%). A média dos níveis de 25(OH)-vitamina D foi de 26,3 ? 8,4 ng/mL. Deficiência e insuficiência de vitamina D foram encontrados em 23,5 e 45,3% dos pacientes, respectivamente. Não houve correlação significativa entre os níveis de vitamina D e as demais variáveis estudadas, exceto o cálcio corrigido para a albumina.
Conclusão: Os pacientes obesos em avaliação para cirurgia bariátrica neste serviço apresentam alta prevalência de deficiência/insuficiência de vitamina D. Estes níveis apresentaram correlação negativa estatisticamente significativa com o cálcio sérico corrigido, mas não com as demais variáveis estudadas.
References
Schuch NJ, Garcia VC, Martini LA. Vitamin D and endocrine diseases. Arq Bras Endocrinol Metab. 2009 Apr; 53(5): 625-33.
Premaor MO, Furlanetto TW. Hipovitaminose D em adultos: entendendo melhor a apresentação de uma velha doença. Arq Bras Endocrinol Metab 2006, Feb; 50/1: 25-37.
Holick MF, Chen TC. Vitamin D deficiency: a worldwide problem with health consequences. Am J Clin Nutr. 2008; 87(suppl):1080S-6S.
Holick MF. The vitamin D deficiency pandemic and consequences for nonskeletal health: mechanisms of action. Mol Aspects Med. 2008, December; 29(6): 361-368.
Rosen CJ, Adams JS, Bikle DD, Black DM, Demay MB, Manson JE, et al. The nonskeletal effects of vitamin D: an Endocrine Society scientific statement. Endocr Rev. 2012, Jun; 33(3): 456-92.
Zhang R, Naughton DP. Vitamin D in health and disease: Current perspectives. Nutrition Journal. 2010, Dec 8; 9:65.
Thacher TD, Clarke BL. Vitamin D insufficiency. Mayo Clin Proc. 2011; 86(1): 50-60.
Holick MF. Vitamin D status: measurement, interpretation, and clinical application. Ann Epidemiol. 2009, Feb; 19(2): 73-78.
Su X, Zemel MB. 1alpha, 25-dihydroxyvitamin D and corticosteroid regulate dipocyte nuclear vitamin D receptor. Int J Obes (Lond). 2008; 32(8): 1305-11.
Instituto Brasileiro de Geografia e Estati?stica. Pesquisa de orc?amentos familiares 2008-2009 : Antropometria e estado nutricional de crianças, adolescentes e adultos no Brasil. Rio de Janeiro 2010.
Kelly T, Yang W, Chen C-S, Reynolds K, He J. Global burden of obesity in 2005 and projections to 2030. International Journal of Obesity. 2008, Sep; 32(9): 1431-7.
Sociedade Brasileira de Nefrologia – Calculadora Nefrocalc 1.0 - Calculadora de Filtração Glomerular e Ajuste de Fármacos em Insuficiência Renal. De autoria do Dr. E. Barsanulfo Pereira do Departamento de Clínica Médica da Faculdade de Medicina da Universidade Federal de Mato Grosso do Sul, Disciplina de Nefrologia, Disciplina de Farmacologia Clínica.
Shane E. Hipocalcemia: pathogenesis, differential diagnosis, and management. In: Favus MJ, editor. Primer on the metabolic bone disease and disorders of mineral metabolism. 4th ed. Philadelphia, Lippincott Williams & Williams; 1999. p.223
Alberti G, Zimmet P, Shaw J, Grundy SM. The IDF consensus worldwide definition of the metabolic syndrome. International Diabetes Federation (IDF), 2006.
Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Murad MH, et al. Evaluation, Treatment, and Prevention of Vitamin D Deficiency: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab, July 2011, 96 (7): 1911–1930.
Maeda SS, Borba VCZ, Camargo MBR, Silva DMW, Borges JLC, Bandeira F, et al. Recomendações da Sociedade Brasileira de Endocrinologia e Metabologia (SBEM) para o diagnóstico e tratamento da hipovitaminose D. Arq Bras Endocrinol Metab.2014 Aug; 58(6): 587-99.
Saraiva GL, Cendoroglo MS, Ramos LR, Araújo LM, Vieira JG, Kunii I, et al. Influence of ultraviolet radiation on the production of 25 hydroxyvitamin D in the elderly population in the city of São Paulo (23 degrees 34'S), Brazil. Osteoporos Int. 2005 Dec;16(12): 1649-54.
Dalcanale L, Oliveira CP, Faintuch J, Nogueira MA, Rondó P, Lima VM, et al. Long-term nutritional outcome after gastric bypass. Obes Surg. 2010 Feb;20(2):181-7.
Biagioni MF, Mendes AL, Nogueira CR, Paiva SA, Leite CV, Mazeto GM. Weight-reducing gastroplasty with Roux-en-Y gastric bypass: impact on vitamin D status and bone remodeling markers. Metab Syndr Relat Disord. 2014 Feb;12(1):11-5.
Casagrande DS, Repetto G, Mottin CC, Shah J, Pietrobon R, Worni M, et al. Changes in bone mineral density in women following 1-year gastric bypass surgery. Obes Surg. 2012 Aug;22(8):1287-92.
Fish E, Beverstein G, Olson D, Reinhardt S, Garren M, Gould J. Vitamin D status of morbidly obese bariatric surgery patients. J Surg Res. 2010 Dec;164(2):198-202.
Grethen E, McClintock R, Gupta CE, Jones R, Cacucci BM, Diaz D, et al. Vitamin D and hyperparathyroidism in obesity. J Clin Endocrinol Metab. 2011 May;96(5):1320-6.
Grace C, Vincent R, Aylwin SJ. High prevalence of vitamin D insufficiency in a United Kingdom urban morbidly obese population: implications for testing and treatment. Surg Obes Relat Dis. 2014 Mar-Apr;10(2):355-60.
Jorde R, Sneve M, Emaus N, Fingeschau Y, Grimnes G. Cross-sectional and longitudinal relation between serum 25-hydroxyvitamin D and body mass index: the Tromsø study. Eur J Nutr. 2010 Oct;49(7):401-7.
Arunabh S, Pollack S, Yeh J, Aloia JF. Body fat content and 25-hydroxyvitamin D levels in healthy women. J Clin Endocrinol Metab. 2003 Jan;88(1):157-61.
Barchetta I, De Bernardinis M, Capoccia D, Baroni MG, Fontana M, et al. (2013) Hypovitaminosis D is Independently Associated with Metabolic Syndrome in Obese Patients. PLoS ONE 8(7): e68689.
Pittas AG, Lau J, Hu FB, Dawson-Hughes B. The role of vitamin D and calcium in type 2 diabetes. A systematic review and metaanalysis. J Clin Endocrinol Metab. 2007; 92(6): 2017-29.
Chiu KC, Chu A, Go VL, Saad MF. Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J Clin Nutr. 2004;79(5):820-5.
Scragg R, Sowers M, Bell C; Third National Health and Nutrition Examination Survey. Serum 25-hydroxyvitamin D, diabetes, and ethnicity in the Third National Health and Nutrition Examination Survey. Diabetes Care. 2004;27(12):2813-8.
Zeitz U, Weber K, Soegiarto DW, Wolf E, Balling R, Erben RG. Impaired insulin secretory capacity in mice lacking a functional vitamin D receptor. FASEB J. 2003;17(3):509-11.
Lee SW, Myounghee K, Kim H, Han SS, Lee H, Lee JP, et al. Obesity Modifies the Association between Serum 25-Hydroxyvitamin D and Insulin Resistance in Korean General Population without Increased Fasting Glucose Levels. Tohoku J. Exp. Med., 2014, 234(2), 89-97.
Bellan M, Guzzaloni G, Rinaldi M, Merlotii E, Ferrari C, Tagliaferri A, et al. Altered glucose metabolism rather than naive type 2 diabetes mellitus (T2DM) is related to vitamin D status in severe obesity. Cardiovasc Diabetol. 2014; 13: 57.
Levine MA. Normal Mineral homeostasis – Interplay of Parathyroid Hormone and Vitamin D. In: Hochberg Z, ed. Vitamin D and Rickets. Vol. 6. Basel: Karger, 2003;14-33.
Larsen ER, Mosekilde L, Foldspang A. Vitamin D and calcium supplementation prevents osteoporotic fractures in elderly community dwelling residents: a pragmatic population-based 3-year intervention study. J Bone Miner Res, 2004;19:370–8.
Shapses AS, Lee EJ, Sukumar D, Arvizu RD, Schneider SH. The Effect of Obesity on the Relationship Between Serum Parathyroid Hormone and 25-Hydroxyvitamin D in Women. J Clin Endocrinol Metab. May 2013; 98(5): E886–E890.
Becerra-Tomás N, Estruch R, Bulló M, Casas R, Díaz-López A, Basora J, et al. Increased Serum Calcium Levels and Risk of Type 2 Diabetes in Individuals at High Cardiovascular Risk. Diabetes Care. 2014 Aug 19.
Schnatz PF, Jiang X, Vila-Wright S, Aragaki AK, Nudy M, O'Sullivan DM, et al. Calcium/vitamin D supplementation, serum 25-hydroxyvitamin D concentrations, and cholesterol profiles in the Women's Health Initiative calcium/vitamin D randomized trial. Menopause. 2014 Aug;21(8):823-33.
Clemens TL, Henderson SL, Adams JS, Holick MF. Increase skin pigment reduces the capacity of skin to synthesis vitamin D3. Lancet 1982; 1(8263): 74-76.
Webb AR, Kline L, Holick MF. Influence of season and latitude on the cutaneous synthesis of vitamin D3: exposure to winter sunlight in Boston and Edmonton will not promote vitamin D3 synthesis in human skin. J Clin Endocrinol Metab. 1988 Aug;67(2):373-8.
Downloads
Published
Issue
Section
License
Copyright (c) 2016 Arquivos Catarinenses de Medicina
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Este trabalho está licenciado sob uma licença Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
